作者投稿
专家审稿
编辑办公
邮件订阅
RSS
Standardize Clinical Medication and Improve Maternal and Neonatal Outcomes: Interpretation on Prevention of Group B Streptococcal Early-onset Disease in Newborns: ACOG Committee Opinion, Number 797
-
摘要: B族链球菌(Group B streptococcus, GBS)生殖道定植和母婴传播是导致孕产妇产褥期感染和新生儿感染/死亡的重要原因之一。目前我国尚无统一的GBS筛查策略, 多数医疗机构参考2010年美国疾控中心联合美国妇产科医师协会(the American College of Obstetricians and Gynecologists, ACOG)等制定的《围产期B族链球菌病预防指南》, 有效降低了GBS相关母婴疾病的发生。2020年1月, ACOG发布更新版B族链球菌妊娠期筛查与产时管理共识, 即《预防新生儿早发型B族链球菌病:ACOG委员会共识》, 该共识对GBS筛查策略、筛查注意事项及抗生素预防性用药等内容进行了更新, 本文对相关内容进行详细解读。Abstract: Colonization of Group B streptococcus (GBS) in the reproductive tract and mother-to-child transmission is an important cause of puerperal infection and neonatal infection/death. Currently, there is no unified screening strategy in China, and most medical institutions adopt the guideline of Prevention of perinatal group B streptococcal disease that formulated by the U.S. Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists (ACOG) in 2010. The incidence of GBS related diseases has been reduced significantly. In January 2020, ACOG released a new consensus on GBS screening and intrapartum management:Prevention of Group B Streptococcal Early-Onset Disease in Newborns:ACOG Committee Opinion, Number 797, which updated issues such as timing and procedure for preterm GBS screening andintrapartum antibiotic prophylaxis. Here we present a detailed interpretation on the relevant content.
-
Key words:
- Group B streptococcus /
- screening strategy /
- preventive intervention
利益冲突 无 -
[1] Puopolo KM, Lynfield R, Cummings JJ, et al. Management of Infants at Risk for Group B Streptococcal Disease[J]. Pediatrics, 2019, 144:e20191881. doi: 10.1542/peds.2019-1881 [2] Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015:multistate laboratory and population-based surveillance[J]. JAMA Pediatr, 2019, 173:224-233. doi: 10.1001/jamapediatrics.2018.4826 [3] Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease——revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59:1-36. [4] Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797[J]. Obstet Gynecol, 2020, 135: e51-e72. [5] Russell NJ, Seale AC, O'Sullivan C, et al. Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide:systematic review and meta-analyses[J]. Clin Infect Dis, 2017, 65:S152-S159. doi: 10.1093/cid/cix655 [6] Bianchi-Jassir F, Seale AC, Kohli-Lynch M, et al. Preterm birth associated with group B streptococcus maternal colonization worldwide:systematic review and meta-analyses[J]. Clin Infect Dis, 2017, 65:S133-S142. doi: 10.1093/cid/cix661 [7] Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014[J]. Pediatrics, 2016, 138:e20162013. doi: 10.1542/peds.2016-2013 [8] Virranniemi M, Raudaskoski T, Haapsamo M, et al. The effect of screening-to-labor interval on the sensitivity of late pregnancy culture in the prediction of group B streptococcus colonization at labor:a prospective multicenter cohort study[J]. Acta Obstet Gynecol Scand, 2019, 98:494-499. doi: 10.1111/aogs.13522 [9] 郭琦, 杨启文, 胡静, 等.孕晚期阴道B族链球菌定植的两种筛查方法比较[J].协和医学杂志, 2018, 9:242-245. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201803011 [10] Shenoy ES, Macy E, Rowe T, et al. Evaluation and management of penicillin allergy:a review[J]. JAMA, 2019, 321:188-199. doi: 10.1001/jama.2018.19283 [11] Turrentine MA, Colicchia LC, Hirsch E, et al. Efficiency of screening for the recurrence of antenatal group B streptococ-cus colonization in a subsequent pregnancy:a systematic review and meta-analysis with independent patient data[J]. Am J Perinatol, 2016, 33:510-517. [12] Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 199:Use of Prophylactic Antibiotics in Labor and Delivery[J]. Obstet Gynecol, 2018, 132:e103-e119. doi: 10.1097/AOG.0000000000002833 [13] Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2017, 17:990-1001. doi: 10.1016/S1473-3099(17)30325-0 [14] Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivity to cephalosporins:cross-reactivity and tolerability of penicillins, monobactams, and carbapenems[J]. J Allergy Clin Immunol, 2010, 126:994-999. doi: 10.1016/j.jaci.2010.06.052 [15] Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women[J]. J Clin Microbiol, 2017, 55:412-422. doi: 10.1128/JCM.01615-16 [16] Turrentine MA, Greisinger AJ, Brown KS, et al. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis[J]. Infect Dis Obstet Gynecol, 2013, 2013:525878. [17] Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36[J]. BJOG, 2017, 124: e280-e305. [18] American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. Prelabor Rupture of Membranes:ACOG Practice Bulletin, Number 217[J]. Obstet Gynecol, 2020, 135:e80-e97. doi: 10.1097/AOG.0000000000003700 [19] Committee on Obstetric Practice. Committee Opinion No. 712:Intrapartum Management of Intraamniotic Infection[J]. Obstet Gynecol, 2017, 130:e95-e101. doi: 10.1097/AOG.0000000000002236 [20] 谭婧, 刘兴会, 孙鑫.基于真实世界数据的疾病管理研究[J].协和医学杂志, 2019, 10:284-288. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201903018 -
下载:
点击查看大图
图(3)
计量
- 文章访问数: 552
- HTML全文浏览量: 128
- PDF下载量: 135
- 被引次数: 0
